Quantitative biochemical and cytological markers were used in a pilot study to quantitate the effects of benzidine (92875) exposure in a well characterized cohort of workers. Three groups were randomly selected and included a group of 23 bladder cancer cases previously exposed to benzidine, a group of 20 subjects with previous exposure history but not previously diagnosed with bladder cancer, and an unexposed comparison group. Biochemical markers included quantitative fluorescence image analysis cytology (QFIA), conventional urinary cytology, the p300 tumor associated antigen detected with the M344 monoclonal antibody, and p185. Samples were collected in China, and analyzed in the US up to 1 week later. Occupational, medical, and smoking histories were obtained on these workers to identify exogenous risk factors. The results of the pilot study indicated that even in remote locations it was possible to obtain useful data and urine samples for analysis. Abnormal findings were found among the 20 subjects exposed but not diagnosed with cancer by both QFIA cytology and p300 expression and these were later diagnosed as having bladder cancer. It was possible also to detect premalignant changes related to exposure to benzidine. The authors conclude that the feasibility of performing molecular marker field studies to define risks in exposed worker cohorts was demonstrated conclusively by these findings.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.